$ATI

Third-quarter results are scheduled for 6:30 a.m. CT on Oct. 29, before ATI's call.

ATI (NYSE: ATI) will release its third-quarter results on Oct. 29 at 6:30 a.m. CT, followed by a conference call. The call and presentation slides will be available on ATImaterials.com. ATI is a global producer of high-performance materials for aerospace, defense, electronics, medical, and specialty energy applications.

Original reporting
Published Oct 13, 2026, 8:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ATI
Neutral
high confidence
Mentioned
$ATI
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ATINeutralLow
01

Why it matters

The announcement of the earnings‑call date informs traders of when new material on revenue, guidance, and margins will become available, allowing positioning ahead of the release.

02

Market read

Provides timing for ATI's Q3 earnings release; limited immediate impact but useful for pre‑earnings positioning.

03

What to watch

Potential supply‑chain or defense‑budget updates that may be discussed during the call could move the stock.

Relevance 5/10Novelty 5/10Timing: pre‑market on Oct 29

Background

ATI (NYSE:ATI) is a global producer of high‑performance materials for aerospace, defense, electronics, medical and specialty energy markets.

Company-level read

Ticker impact

$ATINeutralHigh confidence
Context

The article announces ATI's third‑quarter results call scheduled for 6:30 a.m. CT on Oct 29, providing the first public notice of the earnings release timing.

Expected impact

neutral as investors await the earnings numbers

Evidence & confidence

Only the schedule is disclosed; no financial metrics or guidance are provided, so price impact is limited to typical anticipation effects.

Market effects

None beyond standard earnings‑season expectations for aerospace & defense materials.

Limited to U.S. investors tracking ATI; no broader regional effect.

Minimal, as ATI is a niche supplier without macro‑level influence.

Counterpoint

If the market has already priced in a strong quarter, the call could trigger a sell‑off on disappointment.

Key entities

  • ATI

    Global materials producer listed on NYSE.

Related articles

$ATIMed

How Investors Are Reacting To ATI (ATI) Record Backlog And Raised Guidance

ATI Inc. raised its 2026 adjusted EBITDA and free cash flow guidance, citing record backlog and strong aerospace and defense demand. The company's updated outlook includes high teens defense growth, reinforcing its long-cycle thesis. ATI's share price is up 64% year-to-date, outpacing its industry group. Key risks include execution challenges and softer demand in industrial and medical sectors.

$ATIMed

ATI Shares Surge 64% YTD: What's Driving the Momentum?

ATI Inc. shares have surged 64% year to date, outperforming the aerospace-defense industry and S&P 500. The company reports strong aerospace and defense demand, a record backlog, and improved profitability. Q2 2026 jet-engine revenue rose 13%, defense sales increased 36% to $162M, and adjusted EBITDA grew 37% to $284.4M. ATI raised its 2026 adjusted EBITDA outlook to $1.135-$1.185B and adjusted free cash flow guidance to $550-$600M.

$ATIMed

4 Top Aerospace & Defense Stocks to Consider as America Commemorates 9/11

Four aerospace and defense stocks (ATI, DCO, IA, LOAR) are highlighted as Strong Buys by Zacks, with strong Q2 earnings and raised guidance. ATI reported $1.26B in sales (+10% YoY), record backlog of $4.4B, and raised 2026 EPS guidance. DCO saw record revenue of $224.5M (+11% YoY) and adjusted EPS of $1.18 (+34% YoY). IA reported $26.7M in sales (+11% YoY) and doubled adjusted EPS to $0.33. LOAR posted $171.6M in sales (+39% YoY) and raised 2026 EPS outlook.

$ATIMed

Extended Strategic Agreements to Support Management’s Full-Year 2026 Guidance Raise for ATI Inc. (ATI)

ATI Inc. (NYSE:ATI) raised its 2026 guidance after Q2 revenue rose 11% YoY to $1.26B, with adjusted EBITDA at $284.4M. The company secured long-term supply deals with BWX Technologies and Boeing, supporting its bullish outlook. However, risks include customer concentration and raw material cost volatility. Analysts remain bullish, with a consensus target price of $255.

$ATIMedAI 9/10

ATI’s (ATI) Record Backlog And Raised Guidance Signal Bigger Ambitions

ATI Inc. (NYSE:ATI) reported Q2 sales of $1.26B, up 11% YoY, with net income rising 50% to $151M. The company raised its full-year 2026 outlook, citing strong demand in aerospace and defense. ATI's backlog reached a record $4.4B, up 18% YoY. CEO Kimberly Fields noted demand outpacing supply, and the company repurchased $50M in shares. However, margins in one segment slipped, and debt increased to fund growth.

$ATIMed

Here's How Much a $1000 Investment in ATI Made 10 Years Ago Would Be Worth Today

ATI Inc., a Pittsburgh-based specialty materials producer, restructured in 2013 and 2020, focusing on High-Performance Materials & Components and Advanced Alloys & Solutions. In Q1 2026, earnings beat estimates but revenues missed. The company benefits from aerospace and defense demand but faces risks from production ramps and supply-chain issues.